Perspectivas del uso de productos fitoterápicos en el tratamiento del insomnio, la ansiedad y desórdenes relacionados.
Resumen
Los trastornos de ansiedad y los desórdenes del sueño afectan a un considerable porcentaje de la sociedad. La importancia de estos problemas radica en las repercusiones que generan tanto a nivel personal como social, con una disminución en la calidad de vida de las personas que los padecen. En muchos casos es necesario recurrir a una intervención farmacológica. En este sentido, además de los fármacos de síntesis con actividad ansiolítica y/o inductora del sueño, que con frecuencia producen efectos no deseados, se dispone en el mercado terapéutico de preparados elaborados con plantas medicinales prácticamente desprovistos de efectos secundarios, tal como es el caso de valeriana, tilo y pasiflora mencionadas en este trabajo.
Palabras clave
Texto completo:
89-95Referencias
Ennaceur A, Michalikova S, van Rensburg R, Chazot PL. Tolerance, sensitization and dependence to diazepam in Balb/c mice exposed to a novel open space anxiety test. Behav Brain Res. 2010; 209(1): 154-64.
Listos J, Talarek S, Fidecka S. Adenosinergic system is involved in development of diazepam tolerance in mice. Pharmacol Biochem Behav. 2010; 94(4): 510-5.
Ramirez OA, Perez MF. The plastic phenomenon underlying the associative processes in the addictive properties of diazepam and other psychoactive drugs. Mini Rev Med Chem. 2009; 9(7): 869-77.
Barbanoj MJ, Urbano G, Antonijoan R, Ballester MR, Valle M. Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers. Neuropsychobiology. 2007; 55(3-4): 203-12.
Svob Strac D, Vlainiæ J, Jazvinsæak Jembrek M, Periciæ D. Differential effects of diazepam treatment and withdrawal on recombinant GABA-A receptor expression and functional coupling. Brain Res. 2008; 1246: 29-40.
Nikaido AM, Ellinwood EH Jr, Heatherly DG, Dubow D. Differential CNS effects of diazepam in elderly adults. Pharmacol Biochem Behav. 1987; 27(2): 273-81.
Tada K, Sato Y, Sakai T, Ueda N, Kasamo K, Kojima T. Effects of zopiclone, triazolam, and nitrazepam on standing steadiness. Neuropsychobiology. 1994; 29(1): 17-22.
Mets MA, Volkerts ER, Olivier B, Verster JC. Effect of hypnotic drugs on body balance and standing steadiness. Sleep Med Rev. 2010; 14(4): 259-67.
Rosecrans J, Defoo J, Youngken H. Pharmacologycal investigation of certain Valeriana officinalis extracts. J Pharm Sci 1961; 50:240-244.
Campbell D, Richter W. An observational method estimating toxicity and drug actions in mice applied to 68 reference drugs. Acta Pharmacol Toxicol. 1967; 25: 345-363.
Leuschner J, Muller J, Rudmann M. Characterization of the central nervous depressant activity of a commercial available valerian root extract. Arzneim. Forch. Drug Res. 1993; 43(1): 638-641.
Hiller K, Zetler G. Neuropharmacological studies on ethanol extracts of Valerina officinalis. Behavioural and anticonvulsivant properties. Phytother. Res. 1996; 10: 145-151.
Mirnov VN. Change of the blood coagulation process under the action of valerian. Farmakol Toksikol. 1966; 29(2): 187-8.
Houghton PJ. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol. 1999; 51(5): 505-512.
Houghton PJ. The biological activity of valerian and related plants. J Etnopharmacol 1988; 22: 121-142.
Broncano J, Fernández M, Revuelta M, Carrasco L. Étude del’effet sur le centre du sommeil de différent extraits obtenus de Valeriana montana. Plant Méd Phytothér 1984; 18(3):175-180.
Schumacher B, Scholler S, Holzl J, Khudeir N, Hess S, Muller C. Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A1 adenosine receptors. J Nat Prod. 2002; 65(10): 1479-1485.
Muller C, Schumacher B, Brattstrom A, Abourashed E, Koetter U. Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci 2002; 71(16): 1939-1949.
Hikino H, Hikino Y, Kobinata H, Aizawa A, Kono C, Ohizumi Y. Study on the efficacy of oriental drugs. Sedative properties of valeriana roots. Sho Yakugaku Zasshi 1980; 34:19-24.
Schultz h, Stolz C, Muller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry 1994; 27(4): 147-151.
Marder M, Wasowski C, Paladini A. Las plantas productoras de drogas farmaceúticas. Ciencia Hoy 2001; 65(11): 12-19.
Mennini T, Bernasconi P, Bombardelli E et al. In vitro study on the interaction of extracts and pure compounds of Valerina officinalis roots with GABA benzodiazepine and barbirate receptors. Fitoterapia 1993; 54(4): 291-300.
Müller CE. A1 adenosine receptors and their ligands: overview and recent developments. Farmaco. 2001; 56(1-2): 77-80.
Rezvani ME, Roohbakhsh A, Allahtavakoli M, Shamsizadeh A. Anticonvulsant effect of aqueous extract of Valeriana officinalis in amygdala-kindled rats: possible involvement of adenosine. J Ethnopharmacol. 2010; 127(2): 313-8.
Riedel E, Hänsel R, Ehrke G. Inhibition of gamma-aminobutyric Acid Catabolism by Valerenic Acid Derivatives. Planta Med. 1982; 46(12): 219-220.
Medina JH, Peña C, Levi de Stein M, Wolfman C, Paladini AC. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem Biophys Res Commun. 1989; 165(2): 547-53.
Ortiz JG, Nieves-Natal J, Chavez P. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem Res. 1999; 24(11): 1373-8.
Santos MS, Ferreira F, Cunha AP, Carvalho AP, Ribeiro CF, Macedo T. Synaptosomal GABA release as influenced by valerian root extract-involvement of the GABA carrier. Arch Int Pharmacodyn Ther. 1994; 327(2): 220-31.
Morazzoni P, Bombardelli E. Valeriana officinalis: traditional use and recent evaluation of activity. Fitoterapia 1995; 66(2): 99-112.
Buchbauer G, Jager W, Jirovetz L, Meyer F, Dietrich H. [Effects of valerian root oil, borneol, isoborneol, bornyl acetate and isobornyl acetate on the motility of laboratory animals (mice) after inhalation]. Wirkungen von Baldrianol, Borneol, Isoborneol, Bornylacetat und Isobornylacetat auf die Motilitat von Versuchstieren (Mausen) nach Inhalation. Pharmazie 1992; 47(8):620-2.
Komori T, Matsumoto T, Motomura E, Shiroyama T. The sleep-enhancing effect of valerian inhalation and sleep-shortening effect of lemon inhalation. Chem Senses. 2006; 31(8): 731-7.
Gerhard U, Hobi V, Kocher R, König C. Acute sedative effect of a herbal relaxation tablet as compared to that of bromazepam. Schweiz Rundsch Med Prax. 1991; 80(52): 1481-6.
Leuschner J, Müller J, Rudmann M. Characterisation of the central nervous depressant activity of a commercially available valerian root extract. Arzneimittelforschung. 1993; 43(6): 638-41.
Granger RE, Campbell EL, Johnston GA. (+)- And (-)-borneol: efficacious positive modulators of GABA action at human recombinant alpha1beta2gamma2L GABA(A) receptors. Biochem Pharmacol. 2005; 69(7): 1101-11.
Leathwood PD, Chauffard F, Heck E, Munoz-Box R. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav. 1982; 17(1): 65-71.
Morin CM, Koetter U, Bastien C, Ware JC, Wooten V. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep. 2005 ; 28(11): 1465-71.
Francis AJ, Dempster RJ. Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomised trial. Phytomedicine. 2002; 9(4): 273-9.
Poyares DR, Guilleminault C, Ohayon MM, Tufik S. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(3): 539-45.
Dellamea A. Ansiolíticos naturales: investigación. Farmacia Profesional 1994; 1: 18-19.
Medina J, Peña C, Levi de Stein M, Wolfman C, Paladini A. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biophys Res Comm. 1989; 165(2):547-53.
Lutomski J. Isolation of the major alkaloids from Passiflora incarnata L. Biul. Inst. Roslin Leczniczych. 1961; 6: 209-219.
Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav. 1994; 47(1):1-4.
Della Loggia R, Tubaro A, Redaelli C. Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them. Riv Neurol. 1981; 51(5):297-310.
Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, Mortier F. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J Ethnopharmacol. 1997;57(1):11-20.
Petry RD, Reginatto F, de-Paris F et al. Comparative pharmacological study of hydroethanol extracts of Passiflora alata and Passiflora edulis leaves. Phytother Res. 2001;15(2):162-4.
Marder M, Viola H, Wasowski C et al. 6-Bromoflavone, a high affinity ligand for the central benzodiazepine receptors is a member of a family of active flavonoids. Biochem Biophys Res Commun. 1996; 223(2):384-9.
Zanoli P, Avallone R, Baraldi M. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia. 2000; 71 Suppl 1:S117-23.
Wolfman C, Viola H, Marder M et al. Anxioselective properties of 6,3'-dinitroflavone, a high-affinity benzodiazepine receptor ligand. Eur J Pharmacol. 1996; 318(1):23-30.
Medina JH, Paladini AC, Wolfman C et al. Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem Pharmacol. 1990; 40(10): 2227-31.
Parrillo SJ. Migraine classification and pathophysiology. Ann Emerg Med. 1997; 29(6):825-6.
Moro CO, Basile G. Obesity and medicinal plants. Fitoterapia. 2000; 71 Suppl 1: S73-82.
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2019 Alejandro Bucciarelli, Esteban Jouglard, María de las Mercedes Mancini, Romina Lloret, Ariel Rubio, Mario Skliar
Asociación Médica de Bahía Blanca - Castelli 213 - B8000AIE Bahía Blanca - Buenos Aires - Argentina - https://www.ambb.org.ar